V. Jarlier and I. Arnaud, Surveillance des bactéries multi-résistantes dans les établissements de santé, Réseau BMR, vol.112, 2017.

H. Knothe, P. Shah, V. Krcmery, M. Antal, and S. Mitsuhashi, Ubertragbare Resistenz gegen??ber Cefotaxim, Cefoxitin, Cefamandol und Cefuroxim in klinischen Isolaten von Klebsiella pneumoniae und Serratia marcescens, Infection, vol.147, issue.6, pp.315-322, 1983.
DOI : 10.1007/BF01641355

H. Conseil-de-sécurité-public, Recommandations relatives aux mesures à mettre en oeuvre pour prévenir l'émergence des entérobactéries BLSE et lutter contre leur dissémination. Fevrier Accessible à https, 2010.

D. Meunier, E. Jouy, C. Lazizzera, M. Kobisch, and J. Madec, CTX-M-1- and CTX-M-15-type ??-lactamases in clinical Escherichia coli isolates recovered from food-producing animals in France, International Journal of Antimicrobial Agents, vol.28, issue.5, pp.402-409, 2006.
DOI : 10.1016/j.ijantimicag.2006.08.016

URL : https://hal.archives-ouvertes.fr/hal-00420302

P. Ho, W. Poon, S. Loke, M. Leung, K. Chow et al., Community emergence of CTX-M type extended-spectrum ??-lactamases among urinary Escherichia coli from women, Journal of Antimicrobial Chemotherapy, vol.59, issue.1, pp.140-144, 2007.
DOI : 10.1093/jac/dkl483

J. Rodríguez-baño, L. López-cerero, M. Navarro, P. Díaz-de-alba, and A. Pascual, Faecal carriage of extended-spectrum ??-lactamase-producing Escherichia coli: prevalence, risk factors and molecular epidemiology, Journal of Antimicrobial Chemotherapy, vol.18, issue.1, pp.1142-1151, 2008.
DOI : 10.1017/S0950268806005917

, European Centre for Disease Prevention and Control. Surveillance of antimicrobial resistance in Europe 2016 Annual Report of the European Antimicrobial Resistance Surveillance Network (EARS-Net) Stockholm: ECDC, 2017.

, Morbidité et mortalité des infections à bactéries multi-résistantes aux antibiotiques en France en 2012 Étude Burden BMR, rapport -Juin 2015. Saint-Maurice : Institut de veille sanitaire, 2015.

E. Trecarichi, R. Cauda, and M. Tumbarello, bloodstream infections, Future Microbiology, vol.39, issue.10, pp.1173-89, 2012.
DOI : 10.1093/cid/cir790

K. Laupland, D. Church, J. Vidakovich, M. Mucenski, and J. Pitout, Community-onset extended-spectrum ??-lactamase (ESBL) producing Escherichia coli: Importance of international travel, Journal of Infection, vol.57, issue.6, pp.441-449, 2008.
DOI : 10.1016/j.jinf.2008.09.034

, Société de Pathologie Infectieuse de Langue Française Diagnostic et antibiothérapie des infections urinaires bactériennes communautaires de l'adulte

, World Health Organization, éditeur Antimicrobial resistance: global report on surveillance World Health Organization, 2014.

M. Schwaber and Y. Carmeli, Mortality and delay in effective therapy associated with extended-spectrum ??-lactamase production in Enterobacteriaceae bacteraemia: a systematic review and meta-analysis, Journal of Antimicrobial Chemotherapy, vol.60, issue.5, pp.913-933, 2007.
DOI : 10.1093/jac/dkm318

M. Singer, C. Deutschman, C. Seymour, M. Shankar-hari, D. Annane et al., Third International Consensus Definitions for Sepsis and Septic Shock

, JAMA, vol.315, issue.8, pp.801-811, 2016.

A. Suarez-de-la-rica, F. Gilsanz, and E. Maseda, Epidemiologic trends of sepsis in western countries, Annals of Translational Medicine, vol.4, issue.17, p.325, 2016.
DOI : 10.21037/atm.2016.08.59

G. Martin, D. Mannino, S. Eaton, and M. Moss, The Epidemiology of Sepsis in the United States from 1979 through 2000, New England Journal of Medicine, vol.348, issue.16, pp.1546-54, 2000.
DOI : 10.1056/NEJMoa022139

J. Quenot, C. Binquet, F. Kara, O. Martinet, F. Ganster et al., The epidemiology of septic shock in French intensive care units: the prospective multicenter cohort EPISS study, Critical Care, vol.17, issue.2, p.65, 2013.
DOI : 10.1186/cc12598

URL : https://hal.archives-ouvertes.fr/inserm-00873494

E. Rivers, B. Nguyen, S. Havstad, J. Ressler, A. Muzzin et al., Early Goal-Directed Therapy in the Treatment of Severe Sepsis and Septic Shock, New England Journal of Medicine, vol.345, issue.19, pp.1368-77, 2001.
DOI : 10.1056/NEJMoa010307

Y. Freund, N. Lemachatti, E. Krastinova, M. Van-laer, Y. Claessens et al.,

, Critères de SEPSIS-3 aux urgences : étude prospective internationale de validation du qSOFA (the SCREEN study) Médecine et Maladies Infectieuses, p.7, 2017.

J. Bédos, B. Allaouchiche, L. Armand-lefèvre, O. Baldesi, L. Bouadma et al.,

, Stratégies de réduction de l'utilisation des antibiotiques à visée curative en réanimation (adulte et pédiatrique), Réanimation, vol.23, issue.5, pp.558-82, 2014.

V. Rieux, C. Carbon, and E. Azoulay-dupuis, The Journal of Infectious Diseases, vol.184, issue.1, pp.66-72, 2001.
DOI : 10.1086/320992

M. Vading, M. Kabir, M. Kalin, A. Iversen, S. Wiklund et al., in travellers, Journal of Antimicrobial Chemotherapy, vol.67, issue.12, pp.3548-55, 2016.
DOI : 10.1111/1469-0691.12099

L. Lambertsen, Z. Harboe, H. Konradsen, J. Christensen, and A. Hammerum, Non-invasive erythromycin-resistant pneumococcal isolates are more often non-susceptible to more antimicrobial agents than invasive isolates, International Journal of Antimicrobial Agents, vol.35, issue.1, pp.72-77, 2010.
DOI : 10.1016/j.ijantimicag.2009.09.006

URL : https://hal.archives-ouvertes.fr/hal-00556365

L. Kotekani and S. Kotigadde, Virulence determinant and extended spectrum beta-lactamase production in Klebsiella pneumoniae isolated from a tertiary care hospital, South India, J Lab Physicians, vol.10, issue.242, pp.155-61, 2018.

H. Sahly, S. Navon-venezia, L. Roesler, A. Hay, Y. Carmeli et al., Extended-Spectrum ??-Lactamase Production Is Associated with an Increase in Cell Invasion and Expression of Fimbrial Adhesins in Klebsiella pneumoniae, Antimicrobial Agents and Chemotherapy, vol.52, issue.9, pp.3029-3063, 2008.
DOI : 10.1128/AAC.00010-08

S. Li, Y. Qu, D. Hu, and Y. Shi, Comparison of extended spectrum ??????-lactamases-producing Escherichia coli with non-ESBLsproducing E.coli: drug-resistance and virulence, World Journal of Emergency Medicine, vol.3, issue.3, pp.208-220, 2012.
DOI : 10.5847/wjem.j.issn.1920-8642.2012.03.009

H. Namikawa, K. Yamada, H. Fujimoto, K. Oinuma, Y. Tochino et al., Clinical Characteristics of Bacteremia Caused by Extended-spectrum Beta-lactamase-producing <i>Escherichia coli</i> at a Tertiary Hospital, Internal Medicine, vol.56, issue.14, pp.1807-1822, 2017.
DOI : 10.2169/internalmedicine.56.7702

W. Rottier, H. Ammerlaan, and M. Bonten, Effects of confounders and intermediates on the association of bacteraemia caused by extended-spectrum ??-lactamase-producing Enterobacteriaceae and patient outcome: a meta-analysis, Journal of Antimicrobial Chemotherapy, vol.45, issue.6, pp.1311-1331, 2012.
DOI : 10.1086/522799

E. Aguiar, L. Maciel, M. Halpern, A. De-lemos, A. Ferreira et al., Outcome of Bacteremia Caused by Extended-Spectrum ??-Lactamase???Producing Enterobacteriaceae After Solid Organ Transplantation, Transplantation Proceedings, vol.46, issue.6, pp.1753-1759, 2014.
DOI : 10.1016/j.transproceed.2014.05.003

C. Kang, J. Song, D. Chung, K. Peck, K. Ko et al., Risk factors and treatment outcomes of community-onset bacteraemia caused by extended-spectrum ??-lactamase-producing Escherichia coli, International Journal of Antimicrobial Agents, vol.36, issue.3, pp.284-291, 2010.
DOI : 10.1016/j.ijantimicag.2010.05.009

C. Kang, D. Chung, K. Ko, K. Peck, and J. Song, Risk factors for infection and treatment outcome of extended-spectrum ??-lactamase-producing Escherichia coli and Klebsiella pneumoniae bacteremia in patients with hematologic malignancy, Annals of Hematology, vol.50, issue.Suppl 3, pp.115-136, 2012.
DOI : 10.1128/AAC.50.2.498-504.2006

D. Marchaim, T. Gottesman, O. Schwartz, M. Korem, Y. Maor et al., National Multicenter Study of Predictors and Outcomes of Bacteremia upon Hospital Admission Caused by Enterobacteriaceae Producing Extended-Spectrum ??-Lactamases, Antimicrobial Agents and Chemotherapy, vol.54, issue.12, pp.5099-104, 2010.
DOI : 10.1128/AAC.00565-10

H. Cheong, C. Kang, K. Kwon, S. Heo, Y. Wi et al., Clinical significance of healthcare-associated infections in community-onset Escherichia coli bacteraemia, Journal of Antimicrobial Chemotherapy, vol.60, issue.6, pp.1355-60, 2007.
DOI : 10.1093/jac/dkm378

R. Álvarez, L. Viñas-castillo, J. Lepe-jiménez, E. García-cabrera, and J. Cisneros-herreros,

, Time to positivity of blood culture association with clinical presentation, prognosis and ESBL-production in Escherichia coli bacteremia, Eur J Clin Microbiol Infect Dis, vol.31, issue.9, pp.2191-2196, 2012.

F. Ferreira, D. Bota, A. Bross, C. Mélot, and J. Vincent, Serial Evaluation of the SOFA Score to Predict Outcome in Critically Ill Patients, JAMA, vol.286, issue.14, pp.1754-1762, 2001.
DOI : 10.1001/jama.286.14.1754

M. Harboun and J. Ankri, Indices de comorbidité : revue de la littérature et application aux études des populations « âgées, Rev Epidemiol Sante Publique, vol.49, issue.3, pp.287-98, 2001.

A. Barochia, X. Cui, and P. Eichacker, The Surviving Sepsis Campaign???s Revised Sepsis Bundles, Current Infectious Disease Reports, vol.182, issue.6, pp.385-93, 2013.
DOI : 10.1164/rccm.200912-1918OC

URL : http://europepmc.org/articles/pmc3864669?pdf=render

C. Lee, C. Lee, M. Chuang, M. Hong, H. Hsu et al.,

, Am J Emerg Med, vol.30, issue.8, pp.1447-56, 2012.

M. Tumbarello, M. Sanguinetti, E. Montuori, E. Trecarichi, B. Posteraro et al., Predictors of Mortality in Patients with Bloodstream Infections Caused by Extended-Spectrum-??-Lactamase-Producing Enterobacteriaceae: Importance of Inadequate Initial Antimicrobial Treatment, Antimicrobial Agents and Chemotherapy, vol.51, issue.6, pp.1987-94, 2007.
DOI : 10.1128/AAC.01509-06

G. Peralta, M. Lamelo, P. Álvarez-garcía, M. Velasco, A. Delgado et al., Impact of empirical treatment in extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. bacteremia. A multicentric cohort study, BMC Infectious Diseases, vol.165, issue.Suppl 2, p.245, 2012.
DOI : 10.1001/archinte.165.12.1375

J. Rodríguez-baño, M. Navarro, P. Retamar, E. Picón, and Á. Pascual, ??-Lactam/??-Lactam Inhibitor Combinations for the Treatment of Bacteremia Due to Extended-Spectrum ??-Lactamase-Producing Escherichia coli: A Post Hoc Analysis of Prospective Cohorts, Clinical Infectious Diseases, vol.44, issue.3, pp.167-74, 2012.
DOI : 10.1086/510590

P. Tamma, J. Han, C. Rock, A. Harris, E. Lautenbach et al., Carbapenem Therapy Is Associated With Improved Survival Compared With Piperacillin-Tazobactam for Patients With Extended-Spectrum ??-Lactamase Bacteremia, Clinical Infectious Diseases, vol.54, issue.7, pp.1319-1344, 2015.
DOI : 10.1128/AAC.01808-09

URL : https://academic.oup.com/cid/article-pdf/60/9/1319/1129246/civ003.pdf

D. Keh, E. Trips, G. Marx, S. Wirtz, E. Abduljawwad et al., Effect of Hydrocortisone on Development of Shock Among Patients With Severe Sepsis, JAMA, vol.316, issue.17, pp.3161775-85, 2016.
DOI : 10.1001/jama.2016.14799